Evaluation and Selection of the Patient with Alcoholic Liver Disease for Liver Transplant

被引：31

作者：

Leong, Jennifer ^{[1
]}

Im, Gene Y. ^{[1
]}

机构：

[1] Mt Sinai Sch Med, Recanati Miller Transplantat Inst, New York, NY 10029 USA

来源：

CLINICS IN LIVER DISEASE | 2012年 / 16卷 / 04期

关键词：

Alcoholic liver disease; Alcoholic hepatitis; Liver transplantation; Relapse; Evaluation; PROGNOSTIC-FACTORS; NATURAL-HISTORY; TERM SURVIVAL; UNITED-STATES; SUBSTANCE USE; RISK-FACTORS; FOLLOW-UP; HEPATITIS; RELAPSE; PREDICTORS;

D O I：

10.1016/j.cld.2012.08.012

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

Alcoholic liver cirrhosis is the second most common indication for liver transplantation in the United States. Studies have shown that these patients do as well as those transplanted for nonalcoholic liver disease. Recently, transplantation of patients with alcoholic liver disease has come under closer scrutiny following an article in the New England Journal of Medicine demonstrating comparable outcomes and survival in patients transplanted for acute alcoholic hepatitis. This article reviews the literature and data on the evaluation and selection of patients with alcoholic cirrhosis for liver transplant, and discusses the most recent indication (once a contraindication), acute alcoholic hepatitis.

引用

页码：851 / +

页数：15

共 69 条

[1]

ALEXANDER JF, 1971, AM J GASTROENTEROL, V56, P515

[2]

Recommendations for alcohol-related liver disease [J].

Bathgate, AJ .

LANCET, 2006, 367 (9528) :2045-2046

[3]

Beresford T P, 1997, Liver Transpl Surg, V3, P280, DOI 10.1002/lt.500030314

[4]

EFFICACY OF LIVER-TRANSPLANTATION FOR ALCOHOLIC CIRRHOSIS WITH RESPECT TO RECIDIVISM AND COMPLIANCE [J].

BERLAKOVICH, GA ;

STEININGER, R ;

HERBST, F ;

BARLAN, M ;

MITTLBOCK, M ;

MUHLBACHER, F .

TRANSPLANTATION, 1994, 58 (05) :560-565

[5]

BOROWSKY SA, 1981, GASTROENTEROLOGY, V80, P1405

[6]

Consensus Conference:: Indications for liver transplantation, January 19 and 20, 2005, Lyon-Palais des Congres -: Text of recommendations (long version) [J].

Boudjema, K ;

Samuel, D ;

Balabaud, C ;

Belghiti, J ;

Bismuth, H ;

Calmus, Y ;

Chazouillères, O ;

Cherqui, D ;

Chiche, L ;

Cohen, S ;

Dosquet, P ;

Duvoux, C ;

Jacquelinet, C ;

Launois, B ;

LeToublon, C ;

Messner, M ;

Pageaux, GP ;

Paindavoine, C ;

Partensky, C ;

Sicard, D ;

Benyamina, A ;

Duplan, AB ;

Bronowicki, JP ;

Danet, C ;

Gendrel, D ;

Hourmant, M ;

Lazorthes, F ;

le Loup, G ;

Nancy, JL ;

Pariente, EA ;

Petitnicolas, C ;

Rousset, H ;

Tirel, PBB ;

Torpier, G ;

Adam, R ;

Azoulay, D ;

Berenguer, M ;

Bismuth, H ;

Boillot, O ;

Boudjema, K ;

Calmus, Y ;

Camby, C ;

Chiche, L ;

Clavien, PA ;

Duclos-Vallee, JC ;

Durand, F ;

Duvoux, C ;

Emond, J ;

Hadengue, A ;

le Treut, YP .

LIVER TRANSPLANTATION, 2006, 12 (06) :998-1011

[7]

Campbell D A Jr, 1997, Liver Transpl Surg, V3, P300, DOI 10.1002/lt.500030317

[8]

METHYLPREDNISOLONE THERAPY IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS - A RANDOMIZED MULTICENTER TRIAL [J].

CARITHERS, RL ;

HERLONG, F ;

DIEHL, AM ;

SHAW, EW ;

COMBES, B ;

FALLON, HJ ;

MADDREY, WC .

ANNALS OF INTERNAL MEDICINE, 1989, 110 (09) :685-690

[9]

Castel H, 2009, HEPATOLOGY, V50, p307A

[10]

CHEDID A, 1991, AM J GASTROENTEROL, V86, P210

← 1 2 3 4 5 6 7 →